Keyphrases
Meta-analysis
60%
Heart Failure
50%
Myocardial Infarction
38%
Systematic Meta-analysis
36%
ST-elevation Myocardial Infarction (STEMI)
35%
Readmission
33%
Heart Failure Patients
30%
In-hospital Outcomes
29%
Healing
29%
Nationwide Readmissions Database
28%
Atrial Fibrillation
28%
Heart Failure with Preserved Ejection Fraction (HFpEF)
27%
In-hospital Mortality
26%
Ischemic Stroke
24%
Transcatheter Aortic Valve Replacement
23%
Percutaneous Coronary Intervention
23%
Infarct Healing
23%
Challenging Cases
23%
Hospitalization
22%
Cardiac Amyloidosis
19%
National Inpatient Sample Database
19%
Cryptogenic Stroke
17%
Inflammatory Response
17%
Acute Heart Failure
17%
Cardiogenic Shock
16%
United States
16%
Clinical Characteristics
16%
Etiology
15%
Patients with Heart Failure
15%
Acute Myocardial Infarction
14%
Amyloidosis
14%
Infarct
14%
Confidence Interval
14%
Economic Burden
14%
Coronary Artery Disease
14%
Endomyocardial Biopsy
14%
Odds Ratio
13%
Fibrotic Response
13%
Cardiac Remodeling
13%
Mouse Model
13%
Mechanical Circulatory Support
13%
Acute Ischemic Stroke
12%
Propensity-matched Analysis
11%
Chronic Total Occlusion
11%
Intervention Outcome
11%
Age-specific Trends
11%
Right-sided
11%
Hypertrophic Obstructive Cardiomyopathy
11%
Patients with Obesity
11%
Pulmonary Artery Pressure Monitoring
11%
Medicine and Dentistry
Congestive Heart Failure
100%
Meta-Analysis
47%
Systematic Review
35%
Atrial Fibrillation
31%
Apoplexy
30%
Brain Ischemia
25%
Hospital Mortality
25%
Myocardial Infarction
24%
Percutaneous Aortic Valve Replacement
23%
ST Segment Elevation Myocardial Infarction
23%
Percutaneous Coronary Intervention
23%
Heart Amyloidosis
19%
Cardiogenic Shock
16%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Odds Ratio
15%
Acute Heart Infarction
14%
Coronary Artery Disease
14%
Amyloidosis
14%
National Inpatient Sample
14%
Comorbidity
14%
Chronic Kidney Disease
13%
Heart Muscle Biopsy
13%
Left Ventricular Assist Device
13%
Transplantation
13%
Assisted Circulation
13%
Heart Failure with Reduced Ejection Fraction
12%
Chronic Total Occlusion
11%
Radiation Therapy
11%
Hypertrophic Obstructive Cardiomyopathy
11%
Constrictive Pericarditis
11%
Aortic Valve Replacement
11%
Patient with Obesity
11%
Pericardiectomy
11%
Speckle Tracking Echocardiography
11%
Hand-Schüller-Christian Disease
11%
Granulomatosis with Polyangiitis
11%
Staphylococcus Capitis
11%
COVID-19
11%
Infusion
11%
Hypertrophic Cardiomyopathy
11%
Lung Artery Pressure
11%
Gastrointestinal Bleeding
11%
Microangiopathy
11%
All Cause Mortality
11%
Acetylsalicylic Acid
11%
Infarction
11%
Low Drug Dose
11%
Thrombolytic Drug
11%
Aortic Aneurysm
11%
Heart Ventricle Remodeling
11%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
78%
Heart Infarction
33%
Infarction
28%
Heart Ventricle Remodeling
25%
Hospital Mortality
24%
ST Segment Elevation Myocardial Infarction
23%
Cerebrovascular Accident
17%
Acute Heart Failure
17%
Atrial Fibrillation
15%
Coronary Artery Disease
14%
Acute Heart Infarction
14%
Cardiogenic Shock
14%
Cytokine
14%
Brain Ischemia
14%
Chronic Kidney Failure
13%
Heart Failure with Reduced Ejection Fraction
12%
Myocarditis
12%
Inflammation
12%
Mouse Model
11%
Immune Checkpoint Inhibitor
11%
Thrombus
11%
Aortic Aneurysm
11%
Chronic Total Occlusion
11%
Staphylococcus Capitis
11%
Interleukin 1 Receptor Type I
11%
All Cause Mortality
11%
Guanylate Cyclase
11%
Thrombospondin 1
11%
Amyloidosis
11%
Troponin
11%
Hypertrophic Obstructive Cardiomyopathy
11%
Acetylsalicylic Acid
11%
Endocarditis
11%
Receptor Antagonist
11%
Hypertrophic Cardiomyopathy
11%
Mineralocorticoid Antagonist
11%
Thrombospondin
11%
Coagulase Negative Staphylococcus
11%
Bacterial Endocarditis
11%
Mineralocorticoid
11%
Congenital Heart Disease
11%
Acute Kidney Failure
10%
Adverse Event
10%
Myocardial Disease
9%
Restenosis
8%
Comorbidity
8%
Interleukin 1
8%
Heart Amyloidosis
7%
Placebo
7%
Heart Failure with Preserved Ejection Fraction
7%